Skip to Content

'
Elise D. Cook, M.D., M.S.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

 

She has a special interest and experience in minority recruitment to clinical trials.  Her expertise in recruiting minority patients and community members will also be valuable to SWOG.  She is currently working with Statistical Center Staff on minority recruitment strategies for S0820. Her leadership as PI made UT MD Anderson one of the most successful sites in terms of minority recruitment for the Selenium and Vitamin E Cancer Prevention Trial (SELECT) prostate cancer prevention trial.

Research Interests

  • minority recruitment and retention to clinical trials
  • atrophic vaginitis in breast cancer survivors
  • academic faculty and physician health
  • cancer health disparities

Office Address

The University of Texas MD Anderson Cancer Center
1155 Pressler St.
Unit Number: Unit 1360
Houston, TX 77030
Room Number: CPB6.3530
Email: edcook@mdanderson.org

Education & Training

Degree-Granting Education

1988 University of California, San Francisco, CA, MD, Medicine
1976 Purdue University, West Lafayette, Indiana, MS, Computer Science
1975 Jackson State University, Jackson, MS, BS, Computer Science (Summa Cum Laude)

Board Certifications

2005 Diplomat of American Board of Family Medicine

Experience/Service

Academic Appointments

Assistant Professor, The University of Texas M. D. Anderson Cancer Center, Department of Gynecologic Oncology, Houston, TX, 1992-1994

Other Appointments/Responsibilities

Member, CCOP Underserved Working Group, Houston, TX, 3/2010-10/2010

Professional Memberships

Harris County Medical Society
Member, 1992-present
Texas Academy of Family Physicians
Member, 1991-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Cook ED, Nelson AC. Prostate Cancer Screening. Curr Oncol Rep 13(1):57-62, 2/2011. e-Pub 10/2010. PMID: 20981510.
2. Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM. Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial. Clin Trials 7(1):90-9, 2/2010. NIHMSID: NIHMS395091.
3. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1):39-51, 2009. PMID: 19066370.
4. Cook ED. Selenium and Vitamin E Cancer Prevention Trial--this one's for us. J Natl Med Assoc 94(9):856-8, 9/2002. PMCID: PMCPMC2594152.
5. Mitchell MF, Tortolero-Luna G, Cook ED, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 92(5):737-44, 11/1998. PMID: 9794661.

Invited Articles

1. Cook ED, Mitchell MF. The treatment of cervical intraepithelial neoplasia. Clin Consult in OB/GYN 6:37-43, 1994.

Book Chapters

1. Cook ED. Breast and Prostate Cancer Healthcare Disparities. In: Healthcare Disparities at the Crossroads with Healthcare Reform. Ed(s) Richard Allen Williams. Springer: New York, NY, 385-397, 2011.
2. Cook ED, Gibbs HR. Diverse Academic Faculty: A Precious Resource for Innovative Institutions. In: Faculty Health in Academic Medicine: Physicians, Scientists, and the Pressures of Success. Ed(s) Cole TR, Goodrich, TJ, Gritz, ER. Humana Press: Totowa, NJ, 2008.

Grant & Contract Support

Title: EMPaCT: Enhancing Minority Participation in Clinical Trials: Phase II
Funding Source: NIH/NIMH
Role: Principal Investigator
Duration: 9/19/2011 - 5/31/2016

Last updated: 4/9/2014